$AIZ

BMO Capital Adjusts Price Target on Assurant to $320 From $274, Keeps Outperform Rating

BMO Capital raised its price target for Assurant from $274 to $320, maintaining an Outperform rating. The company's stock is currently trading at $285.41, with a 5-day change of -1.07% and a year-to-date increase of 18.50%.

Original reporting
Published Aug 28, 2026, 10:14 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 12:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$AIZ
Bullish
medium confidence
Mentioned
$AIZ
Relevance
7/10
alphai data visualization · based on marketscreener.com
Decision brief

The 30-second read

$AIZBullishMed
01

Why it matters

The rating change could support short‑term buying interest in Assurant.

02

Market read

Analyst rating change may influence trading decisions in the insurance sector.

03

What to watch

Rising loss ratios and macro volatility are not addressed in the upgrade.

Relevance 7/10Novelty 7/10Timing: pre-market

Background

BMO Capital adjusted Assurant's price target to $320, maintaining an Outperform rating.

Company-level read

Ticker impact

$AIZBullishMedium confidence
Context

BMO Capital raised Assurant's price target to $320 from $274.

Expected impact

Modest price appreciation toward the $320 target.

Evidence & confidence

The higher target reflects improved outlook and may attract buyers, but magnitude is limited.

Market effects

Insurance sector may see slight uplift as rating upgrades improve sentiment.

U.S. equities could experience modest positive bias in property‑casualty insurers.

Impact is limited mainly to U.S. insurance stocks.

Counterpoint

Target increase may be overly optimistic given potential claim cost pressures.

Key entities

  • Assurant

    U.S. insurer whose price target was raised.

  • BMO Capital

    Research arm that issued the price target adjustment.

Related articles

$AIZMedAI 8/10

Assurant (AIZ) Q2 2026 Earnings Call Transcript

Assurant (AIZ) reported Q2 2026 results in an earnings call transcript. Adjusted EBITDA excluding catastrophes rose 18% to $491.4M, and adjusted EPS excluding catastrophes grew 19% to $6.60. Net earned premiums, fees and other income increased 9% to $3.32B. The company revised full-year adjusted EBITDA guidance to mid-single-digit growth and reported $911M liquidity plus $75M Q2 share repurchases.

$AIZMedAI 8/10

Why Assurant (AIZ) Stock Is Trading Up Today

Assurant (AIZ) shares rose about 6.3% after the company reported Q2 2026 results that beat Wall Street. Adjusted EPS was $6.41, above the $5.18 estimate, and up 23.7% year over year. Revenue increased 9.5% to $3.45 billion. Pre-tax margin rose to 10.9%.

$AIZMed

Assurant: Q2 Earnings Snapshot

Assurant Inc. (AIZ) reported Q2 profit of $298.6 million, or $5.95 per share. Adjusted earnings were $6.41 per share versus Zacks’ estimate of $5.16. Revenue was $3.45 billion, with adjusted revenue $3.46 billion versus $3.4 billion expected. Shares were $281.31 at Tuesday’s close.

$AIZMed

ASSURANT, INC. (AIZ): Results of Operations and Financial Condition

ASSURANT, INC. (AIZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Assurant Increases Full Year Outlook, Delivers Record Second Quarter Results Strong Earnings Growth in Global Lifestyle and Global Housing Driving Performance 2026 Outlook Increased to Deliver Mid-Single-Digit Growth Driven by Low Double Digit Global Lifestyle Adjust